Skip to main content
Equibles

UBS Group AG

Position in INKT — MiNK Therapeutics, Inc.

CIK 1610520 ZURICH, V8
Back to INKT Full portfolio

Position in INKT

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$57,105
-$102,972 QoQ
Shares Held
4,885
-67.9% QoQ
Ownership
0.096%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#8
of 27 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in INKT Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

UBS Group AG holds $8,789,675,806 across 561 Biotechnology names. INKT ranks #389 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 5,450,825 $1,020,369,609
2 ROIV
Roivant Sciences Ltd.
 17,466,641 $618,144,423
3 PTGX
Protagonist Therapeutics, Inc
 3,399,221 $416,676,508
4 VRTX
Vertex Pharmaceuticals Inc / Ma
 712,259 $353,800,411
5 MRNA
Moderna, Inc.
 4,463,211 $312,558,664
6 INSM
INSMED Inc
 2,584,446 $275,553,630
7 ABVX
Abivax S.A.
 1,844,918 $245,853,771
8 MDGL
Madrigal Pharmaceuticals, Inc.
 401,708 $215,697,109

All Filings in INKT

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $57,105 4,885
2026-03-31 $160,077 15,202
2025-12-31 $106,459 9,548
2025-09-30 $79,072 5,648
2025-06-30 $2,098 284
2025-03-31 $2,453 284
2024-12-31 $1,984 2,847
2024-09-30 $4,658 6,212
2024-06-30 $3,055 3,221
2024-03-31 $2,933 3,232
2023-12-31 $5,396 5,045
2023-09-30 $3,901 3,547
2023-06-30 $6,614 3,150
2023-03-31 $3,508 1,852
2022-12-31 $6,535 2,504
2022-09-30 $544 258
2022-06-30 $363 258
2022-03-31 $12,061 5,361
2021-12-31 $17,545 3,934